Avellino Labs
Dr. Aldave holds the Walton Li Chair in Cornea and Uveitis and is Chief of the Cornea and Uveitis Division and Director of the Cornea and Refractive Surgery Fellowship Program at the Jules Stein Eye Institute, The University of California, Los Angeles. Dr. Aldave has received numerous honors during his career, including the Alpha Omega Alpha Scholarship Award for graduating first in his medical school class, the Heed Ophthalmic Foundation Fellowship, the American Ophthalmological Society-Knapp Testimonial Fund Fellowship, the first Claes Dohlman Society Award, and the Achievement, Secretariat, and Senior Achievement Awards from the American Academy of Ophthalmology. In addition to his busy clinical practice, Dr. Aldave directs the Corneal Genetics Laboratory at the Jules Stein Eye Institute. Dr. Aldave’s NIH-funded laboratory research focuses on the molecular genetics of corneal dystrophies, a group of inherited disorders that affect corneal clarity and constitute one of the primary indications for corneal transplantation. Recognized as a leader in his chosen field of scientific investigation, Dr. Aldave has authored over 100 peer-reviewed manuscripts, has been invited to give more than 250 scientific presentations at local, national, and international meetings, and serves as a scientific reviewer for 14 ophthalmology and genetics journals.
This person is not in the org chart
This person is not in any offices
Avellino Labs
Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.